Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb;13(2):108-19.
doi: 10.1038/nrurol.2015.301. Epub 2016 Jan 12.

Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome

Affiliations
Review

Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome

Linda Vignozzi et al. Nat Rev Urol. 2016 Feb.

Abstract

Epidemiological studies have shown that age is the principal unmodifiable risk factor of lower urinary tract symptoms (LUTS). Until the past decade, the process of lower urinary tract ageing was, therefore, considered unmodifiable - as ageing per se. However, the traditional dogma that BPH-related LUTS (BPH-LUTS) is an immutable consequence of old age is no longer acceptable. Results from multiple preclinical and clinical studies indicate that several modifiable, age-related metabolic aberrations (metabolic syndrome, obesity, dyslipidaemia, diabetes) are important determinants in both the development and the progression of BPH-LUTS. Metabolic syndrome and its related comorbidities, such as sex steroid alterations and low-grade inflammation, have been related to BPH-LUTS development and progression. With the correct treatment and recommended lifestyle changes, many individuals with metabolic syndrome might be able to prevent or delay the onset of metabolic-syndrome-related complications; however, whether promoting healthier lifestyles can really alter a man's propensity to develop BPH-LUTS remains to be clarified.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Prostate Cancer Prostatic Dis. 2012 Sep;15(3):265-72 - PubMed
    1. Urology. 2012 Jan;79(1):194-201 - PubMed
    1. Physiology (Bethesda). 2014 Sep;29(5):304-13 - PubMed
    1. Eur Urol. 2011 Dec;60(6):1173-80 - PubMed
    1. JAMA. 2015 Sep 8;314(10):1052-62 - PubMed

LinkOut - more resources